Effects of Estradiol on Neural Reward System and Depression in the Perimenopause

雌二醇对神经奖赏系统和围绝经期抑郁症的影响

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Despite decades of research, affective disorders are prevalent and associated with significant morbidity and mortality. Unraveling the pathophysiology of affective disorders has been uniquely challenging because depressive syndromes are heterogeneous and have diverse etiologies. We propose to address this problem by studying perimenopausal major depressive disorder (MDD), a more homogeneous depression subtype with an established trigger (i.e., estradiol withdrawal). Focusing on perimenopausal MDD will therefore increase the likelihood of identifying meaningful neurobiological markers. One of the most powerful tools for understanding the neurobiological mediators of MDD is brain imaging. Prior research suggests that the frontostriatal reward system is regulated by estradiol and implicated in MDD. However, the neural pathophysiology of perimenopausal MDD has never been studied. We will use functional magnetic resonance imaging (fMRI) at baseline and following estradiol treatment to 1) measure the frontostriatal response to reward in perimenopausal MDD and test the effects of estradiol on neural activation in perimenopausal women; 2) quantify behavioral responses to reward at baseline and following estradiol administration in perimenopausal women with and without MDD; and 3) measure the psychological correlates of the frontostriatal response to reward in women with perimenopausal MDD at baseline and following estradiol administration. This study design will allow us to explore the neural pathophysiology of perimenopausal MDD, the effects of estradiol on the neural reward system, and the degree to which neural reward system dysfunction predicts the antidepressant effects of estradiol. This research will support my primary career goal to become an independently funded clinical scientist with the expertise necessary to conduct state-of-the-art mechanistic research on the neuroendocrinology of reproductive mood disorders. My long-term research objectives are to 1) advance our understanding of the effects of ovarian hormones on the brain and how these effects contribute to the triggering of and susceptibility to reproductive-related mood disorders; and 2) to identify neural and endocrine markers of depression risk, thereby improving our ability to prevent affective illness in women. The training and research plan outlined in this proposal are designed to supplement my previous experience with a novel, clinically relevant program of research at the intersection of behavioral endocrinology and neuroscience. The specific objectives to meet my career goal are to 1) obtain focused training in neuroscience and fMRI data acquisition and analysis; 2) develop expertise in neuroendocrinology and hormone administration; 3) gain experience with conducting clinical research in perimenopausal women; and 4) obtain expertise and pilot data to support an interdisciplinary research program principally funded by NIH R01 grants. This career development application represents the critical next step in my academic and research training. Although the ultimate measure of successful training will be the attainment of independent funding by the end of the award period, benchmarks that will be used to determine progress toward my training and research goals include participant enrollment, creation of a data analysis pipeline, manuscript preparation, conference presentations, and grant writing. The proposed training and research activities will prepare me to lead an independently funded research program focused on the neuroendocrine pathophysiology of reproductive mood disorders. In addition to supporting my career development objectives, the proposed research represents the first step in characterizing neural mechanisms of reproductive hormone-related affective dysfunction during the perimenopausal period. The impact of this research is expected to be an improved understanding of the neuroendocrine pathophysiology of perimenopausal MDD. Future directions for this work will include identifying neural biomarkers that predict reproductiv mood disorder susceptibility and response to hormonal interventions, and exploring neuroendocrine etiological pathways that may help to explain the preponderance of depression in women.
 描述(由申请人提供):尽管数十年的研究,情感障碍是普遍存在的,并与显着的发病率和死亡率。由于抑郁综合征是异质性的,病因也多种多样,因此揭示情感性精神障碍的病理生理机制是一个独特的挑战。我们建议通过研究围绝经期重性抑郁症(MDD)来解决这个问题,MDD是一种更同质的抑郁亚型,具有既定的触发因素(即,雌二醇戒断)。因此,关注围绝经期MDD将增加识别有意义的神经生物学标志物的可能性。了解MDD的神经生物学介质的最有力的工具之一是脑成像。先前的研究表明,额纹状体奖励系统是由雌二醇调节,并牵连在MDD。然而,围绝经期MDD的神经病理生理学从未被研究过。我们将在基线和雌二醇治疗后使用功能磁共振成像(fMRI)来1)测量围绝经期MDD患者的额纹状体对奖励的反应,并测试雌二醇对围绝经期女性神经激活的影响; 2)量化有和无MDD的围绝经期女性在基线和雌二醇给药后对奖励的行为反应;和3)测量在基线和雌二醇给药后患有围绝经期MDD的女性的额纹状体对奖励的反应的心理相关性。这项研究设计将使我们能够探索围绝经期MDD的神经病理生理学,雌二醇对神经奖励系统的影响,以及神经奖励系统功能障碍预测雌二醇抗抑郁作用的程度。这项研究将支持我的主要职业目标,成为一名独立资助的临床科学家,拥有对生殖情绪障碍的神经内分泌学进行最先进的机制研究所需的专业知识。我的长期研究目标是:1)促进我们对卵巢激素对大脑的影响的理解,以及这些影响如何导致生殖相关情绪障碍的触发和易感性; 2)确定抑郁风险的神经和内分泌标志物,从而提高我们预防女性情感疾病的能力。本建议书中概述的培训和研究计划旨在补充我以前的经验,在行为内分泌学和神经科学的交叉点上开展一项新颖的临床相关研究计划。实现我的职业目标的具体目标是:1)获得神经科学和功能磁共振成像数据采集和分析方面的重点培训; 2)发展神经内分泌学和激素管理方面的专业知识; 3)获得在围绝经期妇女中进行临床研究的经验; 4)获得专业知识和试点数据,以支持主要由NIH R01资助的跨学科研究计划。这个职业发展应用程序代表了我的学术和研究培训的关键下一步。虽然成功培训的最终衡量标准将是在奖励期结束时获得独立资助,但用于确定我的培训和研究目标进展的基准包括参与者注册,创建数据分析管道,手稿准备,会议演示和赠款写作。拟议的培训和研究活动将准备我领导一个独立资助的研究计划,重点是生殖情绪障碍的神经内分泌病理生理学。除了支持我的职业发展目标,拟议中的研究代表了在围绝经期生殖健康相关的情感功能障碍的神经机制的特征的第一步。这项研究的影响,预计将是一个更好的了解围绝经期MDD的神经内分泌病理生理学。这项工作的未来方向将包括识别预测生殖情绪障碍易感性和对激素干预反应的神经生物标志物,并探索可能有助于解释女性抑郁症优势的神经内分泌病因学途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Crystal Edler Schiller其他文献

Acceptance and commitment therapy for perinatal mood and anxiety disorders: development of an inpatient group intervention
  • DOI:
    10.1007/s00737-017-0735-8
  • 发表时间:
    2017-06-10
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Alexa Bonacquisti;Matthew J. Cohen;Crystal Edler Schiller
  • 通讯作者:
    Crystal Edler Schiller
A Qualitative Study of Religion and Spirituality in a Perinatal Psychiatry Inpatient Unit in the Southeast USA
  • DOI:
    10.1007/s10943-021-01451-y
  • 发表时间:
    2021-11-09
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Ashley Cantu-Weinstein;Matthew J. Cohen;Darryl Owens;Crystal Edler Schiller;Mary C. Kimmel
  • 通讯作者:
    Mary C. Kimmel

Crystal Edler Schiller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Crystal Edler Schiller', 18)}}的其他基金

Characterizing the neural substrates of irritability in women: an experimental neuroendocrine model
表征女性烦躁的神经基础:实验性神经内分泌模型
  • 批准号:
    9981834
  • 财政年份:
    2019
  • 资助金额:
    $ 13.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了